Characteristics | Remote NCT cohort (control or CPAP) (n = 7) | COPE-PAP control cohort (n = 25) |
---|---|---|
Age, years | 60.6 (4.8) | 70.6 (10.1) |
Sex (M/F) | 5/2 | 16/9 |
BMI, kg/m2 | 30.4 (6.8) | 29.7 (4.3) |
Education, years | 16.3 (2.6) | 14.4 (3.2) |
MoCA test score | 23.9 (1.8) | 22.4 (3.0) |
Epworth Sleepiness Scale score | 10.9 (3.0) | 10.6 (4.8) |
Time from PD diagnosis, years | 3.9 (2.2) | 9.2 (7.0) |
Levodopa equivalent dose, mg/day | 374.9 (152.0) | 781.9 (446.8) |
MDS-UPDRS total score | 52.0 (12.2) | 64.9 (17.1) |
MDS-UPDRS part 1 (non-motor experience of daily living) | 12.4 (5.9) | 14.2 (4.7) |
MDS-UPDRS part 3 (motor examination) | 29.1 (7.8) | 31.2 (9.8) |
Sleep apnea variables | ||
AHI, events/hour | 39.8 (11.2) | 40.4 (29.7) |
ODI, events/hour | 14.1 (9.6) | 16.3 (18.8) |
Mean SpO2 | 94.3 (1.6) | 94.1 (1.9) |
Nadir SpO2 | 86.7 (5.1) | 86.2 (7.7) |
T90, % TST | 1.0 (1.4) | 2.5 (4.3) |